[Report on a preliminary open clinical study of mianserin (GB 94), a tetracyclic antidepressant].
D000328:Adult; D000368:Aged; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy; D001381:Azepines / Q000494:pharmacology / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D003220:Conflict, Psychological / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000188:drug therapy; D018492:Dopamine Antagonists; D004569:Electroencephalography; D001068:Feeding and Eating Disorders; D005260:Female; D006801:Humans; D005222:Mental Fatigue; D051379:Mice; D008875:Middle Aged; D011719:Pyrazines / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D012698:Serologic Tests; D012893:Sleep Wake Disorders / Q000188:drug therapy
D000928:Antidepressive Agents; D001381:Azepines; D018492:Dopamine Antagonists; D011719:Pyrazines